Evidence map›Paper›PMID 40515392›Full record

ArticleBriefings in bioinformatics2025

scValue: value-based subsampling of large-scale single-cell transcriptomic data for machine and deep learning tasks.

Li Huang, Weikang Gong, Dongsheng Chen

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Li HuangState Key Laboratory of Common Mechanism Research for Major Diseases, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, 100 Chongwen Road, Suzhou Industrial Park, Suzhou, Jiangsu Province 215123, China.ORCID 0000-0002-9437-4366
Weikang GongState Key Laboratory of Common Mechanism Research for Major Diseases, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, 100 Chongwen Road, Suzhou Industrial Park, Suzhou, Jiangsu Province 215123, China.
Dongsheng ChenState Key Laboratory of Common Mechanism Research for Major Diseases, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, 100 Chongwen Road, Suzhou Industrial Park, Suzhou, Jiangsu Province 215123, China.ORCID 0000-0002-7196-4136

Funding

CAMS Innovation Fund for Medical Sciences (CIFMS) 2021-I2M-1-061, 2022-I2M-2-004, 2023-I2M-2-005China Postdoctoral Science Foundation, the Postdoctoral Fellowship Program (Grade B) GZB20230084Chinese Academy of Medical Sciences & Peking Union Medical College, Union Medical College Young Scholar Support Program 2023086 and 2023088National Natural Science Foundation of China 32300560NCTIB Fund for R&D Platform for Cell and Gene Therapy, the Suzhou Municipal Key Laboratory SZS2022005Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2022-RC416-01Special Research Fund for Central Universities, Peking Union Medical College 3332024089
6 · The paper itself

Abstract

Large single-cell ribonucleic acid-sequencing (scRNA-seq) datasets offer unprecedented biological insights but present substantial computational challenges for visualization and analysis. While existing subsampling methods can enhance efficiency, they may not ensure optimal performance in downstream machine learning and deep learning (ML/DL) tasks. Here, we introduce scValue, a novel approach that ranks individual cells by 'data value' using out-of-bag estimates from a random forest model. scValue prioritizes high-value cells and allocates greater representation to cell types with higher variability in data value, effectively preserving key biological signals within subsamples. We benchmarked scValue on automatic cell-type annotation tasks across four large datasets, paired with distinct ML/DL models. Our method consistently outperformed existing subsampling methods, closely matching full-data performance across all annotation tasks. In three additional case studies-label transfer learning, cross-study label harmonization, and bulk RNA-seq deconvolution-scValue more effectively preserved T-cell annotations across human gut-colon datasets, more accurately reproduced T-cell subtype relationships in a human spleen dataset, and constructed a more reliable single-cell immune reference for cell-type deconvolution in simulated bulk tissue samples. Finally, using 16 public datasets ranging from tens of thousands to millions of cells, we evaluated subsampling quality based on computational time, Gini coefficient, and Hausdorff distance. scValue demonstrated fast execution, well-balanced cell-type representation, and distributional properties akin to uniform sampling. Overall, scValue provides a robust and scalable solution for subsampling large scRNA-seq data in ML/DL workflows. It is available as an open-source Python package installable via pip, with source code at https://github.com/LHBCB/scvalue.

Indexed as

Deep LearningGene Expression ProfilingMachine LearningSingle-Cell AnalysisSoftwareTranscriptomeAlgorithmsComputational BiologyHumansRNA-Seqcell type analysisdata valuationmachine and deep learningsingle-cell transcriptomicssubsampling

Identifiers

PMID40515392
PMCPMC12165832

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.